Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The mechanism by which macrolide antibiotics have immune modifying effects independent from
its antibacterial activity has not been well established. In the present work, the
investigators will analyze the effect of long-term treatment with azithromycin (250 mg three
times per week during three months) on airway oxidative stress markers in exhaled breath
condensate of adult patients with stable non-CF bronchiectasis.